CRP and inflammatory bowel disease: Generally, risk factors for biologic treatment in IBD (UC and CD together) were fever and fatigue at diagnosis, hypoalbuminemia, hypoproteinemia, and elevated CRP; hypoalbuminemia was the most significant predictor.